findmyKOL

Angela Dispenzieri, MD

Enriched profile

Professor of Medicine and of Laboratory Medicine and Pathology; Consultant, Division of Hematology, Department of Internal Medicine (Serene M. and Frances C. Durling Professor of Medicine) · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyHematologyFocusMultiple Myeloma Research and Treatments+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2001–2022

Angela Dispenzieri is Professor of Medicine and of Laboratory Medicine and Pathology; Consultant, Division of Hematology, Department of Internal Medicine (Serene M. and Frances C. Durling Professor of Medicine) at Mayo Clinic. OpenAlex indexes 2,490 publications with 100,475 citations (h-index 146); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology profiles in the findmyKOL directory. Clarivate lists Angela Dispenzieri as a Highly Cited Researcher (Clinical Medicine, 2021; Cross-Field, 2019, 2022-2023).

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Angela Dispenzieri, M.D., is Professor of Medicine and of Laboratory Medicine and Pathology at Mayo Clinic, Rochester, Minnesota. The public record shows 2,490 publications with 100,475 citations (h-index 146), centered on Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Protein Degradation and Inhibitors. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 9 companies, 5 NIH-funded awards (2001–2022).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Multiple Myeloma Research and Treatments
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Myeloma8 trialsAmyloidosis4 trialsST Elevation Myocardial Infarction2 trialsImmunoglobulin Light-chain Amyloidosis2 trialsPain1 trialPlasmacytoma1 trialPOEMS Syndrome1 trialLeukemia (AML/ALL/CML/CLL)

Research focus

OpenAlex concept fingerprint
Multiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, OutcomesProtein Degradation and InhibitorsChronic Lymphocytic Leukemia ResearchCancer Treatment and Pharmacology

Drugs & molecules

across trials, industry payments and publications
Revlimidgeneric · LenalidomideClinical trials2Industry payments3Publications9Stem CellClinical trials1Industry payments—Publications22Darzalexgeneric · DaratumumabClinical trials—Industry payments5Publications13DexamethasoneClinical trials2Industry payments—Publications11BortezomibClinical trials3Industry payments—Publications5MelphalanClinical trials3Industry payments—Publications2IxazomibClinical trials1Industry payments—Publications3CyclophosphamideClinical trials1Industry payments—Publications2SargramostimClinical trials2Industry payments—Publications—111In ZevalinClinical trials1Industry payments—Publications—AlvocidibClinical trials1Industry payments—Publications—IododoxorubicinClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Mayo ClinicClinical trials9Industry payments—Janssen Biotech, Inc.Clinical trials—Industry payments5Celgene CorporationClinical trials—Industry payments4National Cancer Institute (NCI)Clinical trials4Industry payments—Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments4E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Janssen Research & Development, LLCClinical trials—Industry payments3Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3AstraZeneca UK LimitedClinical trials—Industry payments1Legend Biotech USA Inc.Clinical trials—Industry payments1The Binding Site Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,490publications

Distinct works indexed by OpenAlex, matched via ORCID; 194 in PubMed.

100,475citations

Total citations across indexed works.

146h-index

Hirsch index (OpenAlex). i10-index 877.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2001–2022

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

All 13 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 17 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    50.8%
    Other drugs affecting bone structure and mineralization50.8%
    Romosozumab-aqqg100%
    Part B, office-administered≥11 patients

  • Anti-infectives

    42.6%
    SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor42.3%
    Remdesivir100%
    Part B, office-administered≥13 patients
    Short-acting sulfonamides0.3%
    Sulfamethoxazole-Trimethoprim100%
    Part D<11 patients

  • Cancer & immunology

    2%
    Thalidomide Analog1.6%
    Revlimid66%Lenalidomide34%
    Part D<11 patients
    BCL-2 Inhibitor0.4%
    Venclexta100%
    Part D<11 patients
All 9 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)2.1% facility · 97.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

5 NIH research awards on record, funded 2001–2022 per NIH RePORTER. The latest:

All 16 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 194 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
    4,876 citations2014
    doi.org ↗
  2. 02
    Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
    2,432 citations2003
    doi.org ↗
  3. 03
    Improved survival in multiple myeloma and the impact of novel therapies
    2,252 citations2007
    doi.org ↗
  4. 04
    Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
    2,014 citations2016
    doi.org ↗
  5. 05
    Prevalence of Monoclonal Gammopathy of Undetermined Significance
    1,410 citations2006
    doi.org ↗
All 2,490 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Morie A. Gertz1204Shaji Kumar1073Martha Q. Lacy998S. Vincent Rajkumar973Francis K. Buadi861David Dingli783Robert A. Kyle755Suzanne R. Hayman752Prashant Kapoor656Nelson Leung615Wilson I. Gonsalves532Taxiarchis Kourelis500Rahma Warsame434John A. Lust391Eli Muchtar384Ronald S. Go343Stephen J. Russell300Yi L. Hwa295Steven R. Zeldenrust266Yi Lin261Miriam Hobbs259Amie Fonder249Rafaël Fonseca217Philip R. Greipp199Martha Grogan169Moritz Binder160Thomas E. Witzig159William J. Hogan154Stephen M. Ansell111Mark R. Litzow110Surendra Dasari108David Murray107P. Leif Bergsagel104Dirk R. Larson90Vivek Roy90Dragan Jevremović84Joselle Cook81David J. Inwards81Giampaolo Merlini81Mustaqeem Siddiqui79

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/angela-dispenzieri-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/ADispenzieri

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    bloodcancerstoday.com/podcast/angela-dispenzieri-md-on-managing-newly-diagnosed-al-amyloidosis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
  • Other

    vjhemonc.com/speaker/angela-dispenzieri

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Angela-Dispenzieri-2161930600

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • Mayoclinic.org

    Twitter/X handle @Adispenzieri associated with Dr. linked from Mayo Clinic official bio page')

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Resident/Fellow

    Hematology and Oncology, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Board Certification: Hematology

    American Board of Internal Medicine

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Resident

    Internal Medicine, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • MD

    Albert Einstein College of Medicine

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Undergraduate study

    Massachusetts Institute of Technology (per Mayo biographical summary; degree/year not specified on primary page)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗

Editorial & leadership roles

journal and society appointments
  • President

    International Kidney Monoclonal Gammopathy Research Group

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Member

    NCI Myeloma Steering Committee

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Member

    Performance Expectations for Clinical Trialists Taskforce

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Immediate Past President

    International Society of Amyloidosis

    2020
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
  • Treasurer

    International Society of Amyloidosis

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Vice Chair

    Clinical Research Committee, Mayo Clinic Comprehensive Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Chair of Hematology Research

    Mayo Clinic, Rochester, Minnesota

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
  • Member

    Society of Hematologic Oncology (SOHO) Education Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinicaloptions.com ↗

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Clinical Medicine
    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
  • Cross-Field
    201920222023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.